Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Jan 2007 Helping Patients Decide Whether to Participate in Clinical Trials Martin L. Smith, STD and Eric D. Kodish, MD Virtual Mentor. 2007;9(1):16-20. doi: 10.1001/virtualmentor.2007.9.1.ccas3-0701. Health Law Feb 2007 Waiver of Consent in Medical Procedure Research Matthew Stonecipher Virtual Mentor. 2007;9(2):123-127. doi: 10.1001/virtualmentor.2007.9.2.hlaw1-0702. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Jan 2007 Helping Patients Decide Whether to Participate in Clinical Trials Martin L. Smith, STD and Eric D. Kodish, MD Virtual Mentor. 2007;9(1):16-20. doi: 10.1001/virtualmentor.2007.9.1.ccas3-0701.
Health Law Feb 2007 Waiver of Consent in Medical Procedure Research Matthew Stonecipher Virtual Mentor. 2007;9(2):123-127. doi: 10.1001/virtualmentor.2007.9.2.hlaw1-0702.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.